IPCA Labs - Strength in the Pharma sector

One of the few stocks which has had USFDA issues but eventually took it into its stride..
They focused more on the domestic market and now have a strong local franchise.
Long above 960 with a stoploss below 930.
The stock could breakout and move vertically.